1. All Products
  2. DVAC - Vaccines
  3. IMMUNOGLOBULIN HUMAN HEPATITIS B, 180 IU/ml, 1ml, vial
Public Pricelist

IMMUNOGLOBULIN HUMAN HEPATITIS B, 180 IU/ml, 1ml, vial

https://medicalguidelines.msf.org/en/node/286
https://unicat.msf.org/cat/product/73887
STD DVACIMHB1V-

Valid Article

The product is supplied (and stored) sterile, it must remain sterile until its use. Sterile = state of being free from all living microorganisms.
11.2.1 - Human immunoglobulins
Classification of the medicines in groups and subgroups according to their therapeutic use. The classification used by MSF is based on the WHO Model List of Essential Medicines.
J06BB04
Anatomical Therapeutic Chemical Classification according to WHOCC
PME
The order of this product needs to be justified and is only acceptable under certain conditions.
0208
Thermosensitive codes are defined for storage and transportation temperature requirements of the products.
OC subscriptions: included in supply or field order tools (e.g. UniField)
SC subscriptions: included in supply or field tools
OC validations: approved for procurement and use by an OC for international or local orders specifying context and activity in Medical Standard Lists (MSL)

This combination does not exist.

See Related

Add article to list

   
Create Cancel

Add Kit To Wishlist

   
Create Cancel

IMMUNOGLOBULIN HUMAN HEPATITIS B 180 IU/ml

Therapeutic Action

Human Hepatitis B Immunoglobulin contains mainly immunoglobulin G (IgG) with a specifically high content of antibodies against hepatitis B virus surface antigen (HBs).

Indications

Post-exposure prophylaxis (often in combination with hepatitis B vaccine) after an Accidental Exposure to Blood (AEB) in specific settings.

For other indications (post-exposure prophylaxis for victims of sexual violence, newborn of a hepatitis B virus carrier-mother/HBV PMTCT), the added value is limited and restricted to specific situations. In these cases, the request should be evaluated by the HQ advisor on a case-by-case basis and considered as an exception.

Some restricted information has been hidden. Sign in to see this information

Instructions for use

Must be given by IM route.

To be combined with vaccination against hepatitis B virus. The first vaccine dose can be injected the same day as immunoglobulin, in different sites.

Precautions for Use

Do not administer by IV route (risk of anaphylactic shock).

If a large volume (>2 ml for children or >5 ml for adults) is required, administer in divided doses at different sites.

Active immunisation with live virus vaccines (e.g. measles, mumps or rubella) should be postponed for 3 months after the last administration of Human Hepatitis B Immunoglobulin, as the efficacy of the live virus vaccine may be impaired.

As with all injectable vaccines and/or immunoglobulins, appropriate medical treatment should always be readily available in case of rare anaphylactic reactions following the administration of the product.

Storage

  • Keep refrigerated between 2ºC and 8ºC - Protect from sunlight
  • Do not freeze.
  • Do not use solutions that are cloudy or have deposits.

(Cf Introduction: Thermosensitive products)